Leesa Gentry
Chief Clinical Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | RenovoRx, Inc. (RNXT) | Chief Clinical Officer | $339,386 | $890,151 |
| 2023 | RenovoRx, Inc. (RNXT) | Chief Clinical Officer | — | — |
Executive changes
Earnings-call appearances
No earnings-call appearances recorded yet.